These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 9664131

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Cytocidal activity of PBL, LAK, and IDEC-C2B8 and expression of HLA class 1, ICAM-1, and CD20 in vincristine-resistant hematologic cell lines.
    Hirose M, Hamano S, Tobinai K, Kuroda Y.
    J Immunother; 1999 May; 22(3):237-44. PubMed ID: 10335483
    [Abstract] [Full Text] [Related]

  • 24. Effect of glucose transport inhibitors on vincristine efflux in multidrug-resistant murine erythroleukaemia cells overexpressing the multidrug resistance-associated protein (MRP) and two glucose transport proteins, GLUT1 and GLUT3.
    Martell RL, Slapak CA, Levy SB.
    Br J Cancer; 1997 May; 75(2):161-8. PubMed ID: 9010020
    [Abstract] [Full Text] [Related]

  • 25. Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublines in vitro.
    Hill BT, Whelan RD, Shellard SA, McClean S, Hosking LK.
    Invest New Drugs; 1994 May; 12(3):169-82. PubMed ID: 7896535
    [Abstract] [Full Text] [Related]

  • 26. Development of novel reversal agents, imidazothiazole derivatives, targeting MDR1- and MRP-mediated multidrug resistance.
    Naito S, Koike K, Ono M, Machida T, Tasaka S, Kiue A, Koga H, Kumazawa J.
    Oncol Res; 1998 May; 10(3):123-32. PubMed ID: 9700723
    [Abstract] [Full Text] [Related]

  • 27. Probenecid reverses multidrug resistance in multidrug resistance-associated protein-overexpressing HL60/AR and H69/AR cells but not in P-glycoprotein-overexpressing HL60/Tax and P388/ADR cells.
    Gollapudi S, Kim CH, Tran BN, Sangha S, Gupta S.
    Cancer Chemother Pharmacol; 1997 May; 40(2):150-8. PubMed ID: 9182837
    [Abstract] [Full Text] [Related]

  • 28. Potentiation of some anticancer agents by dipyridamole against drug-sensitive and drug-resistant cancer cell lines.
    Asoh K, Saburi Y, Sato S, Nogae I, Kohno K, Kuwano M.
    Jpn J Cancer Res; 1989 May; 80(5):475-81. PubMed ID: 2568984
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Increased sensitivity to vincristine of MDR cells by the leukotriene D4 receptor antagonist, ONO-1078.
    Nagayama S, Chen ZS, Kitazono M, Takebayashi Y, Niwa K, Yamada K, Tani A, Haraguchi M, Sumizawa T, Furukawa T, Aikou T, Akiyama S.
    Cancer Lett; 1998 Aug 14; 130(1-2):175-82. PubMed ID: 9751271
    [Abstract] [Full Text] [Related]

  • 31. BIRICODAR (VX-710; Incel): an effective chemosensitizer in neuroblastoma.
    Yanagisawa T, Newman A, Coley H, Renshaw J, Pinkerton CR, Pritchard-Jones K.
    Br J Cancer; 1999 Jun 14; 80(8):1190-6. PubMed ID: 10376971
    [Abstract] [Full Text] [Related]

  • 32. Altered MRP is associated with multidrug resistance and reduced drug accumulation in human SW-1573 cells.
    Eijdems EW, Zaman GJ, de Haas M, Versantvoort CH, Flens MJ, Scheper RJ, Kamst E, Borst P, Baas F.
    Br J Cancer; 1995 Aug 14; 72(2):298-306. PubMed ID: 7640209
    [Abstract] [Full Text] [Related]

  • 33. Correlation between permeability-related glycoprotein expression and susceptibilty to oxygen radicals in vincristine-resistant hematologic cell lines.
    Hirose M, Hamano S, Hosoi E, Kuroda Y.
    Cancer Lett; 1997 Dec 09; 120(2):179-84. PubMed ID: 9461035
    [Abstract] [Full Text] [Related]

  • 34. P-glycoprotein and multidrug resistance-associated protein mediate specific patterns of multidrug resistance in malignant glioma cell lines, but not in primary glioma cells.
    Bähr O, Rieger J, Duffner F, Meyermann R, Weller M, Wick W.
    Brain Pathol; 2003 Oct 09; 13(4):482-94. PubMed ID: 14655754
    [Abstract] [Full Text] [Related]

  • 35. Reversal of multidrug resistance in drug-resistant human gastric cancer cell line SGC7901/VCR by antiprogestin drug mifepristone.
    Li DQ, Wang ZB, Bai J, Zhao J, Wang Y, Hu K, Du YH.
    World J Gastroenterol; 2004 Jun 15; 10(12):1722-5. PubMed ID: 15188493
    [Abstract] [Full Text] [Related]

  • 36. Expression of multidrug resistance-associated protein (MRP), MDR1 and DNA topoisomerase II in human multidrug-resistant bladder cancer cell lines.
    Hasegawa S, Abe T, Naito S, Kotoh S, Kumazawa J, Hipfner DR, Deeley RG, Cole SP, Kuwano M.
    Br J Cancer; 1995 May 15; 71(5):907-13. PubMed ID: 7734314
    [Abstract] [Full Text] [Related]

  • 37. Reversal effect of bufalin on multidrug resistance in K562/VCR vincristine-resistant leukemia cell line.
    Zhai X, Lu J, Wang Y, Fang F, Li B, Gu W.
    J Tradit Chin Med; 2014 Dec 15; 34(6):678-83. PubMed ID: 25618972
    [Abstract] [Full Text] [Related]

  • 38. Multidrug resistance reversal activity of taxoids from Taxus cuspidata in KB-C2 and 2780AD cells.
    Kobayashi J, Shigemori H, Hosoyama H, Chen Z, Akiyama S, Naito M, Tsuruo T.
    Jpn J Cancer Res; 2000 Jun 15; 91(6):638-42. PubMed ID: 10874217
    [Abstract] [Full Text] [Related]

  • 39. Hyperin Enhances the Sensitivity of HCT8/VCR Colon Cancer Cell Line to Vincristine by Down-Regulating P-Glycoprotein.
    Wang LM, Zhang MY, Zhu QS, Lu CF, Bai X.
    Clin Lab; 2018 Mar 01; 64(3):269-275. PubMed ID: 29739100
    [Abstract] [Full Text] [Related]

  • 40. Reversal of multidrug resistance-associated protein-mediated drug resistance by the pyridine analog PAK-104P.
    Sumizawa T, Chen ZS, Chuman Y, Seto K, Furukawa T, Haraguchi M, Tani A, Shudo N, Akiyama SI.
    Mol Pharmacol; 1997 Mar 01; 51(3):399-405. PubMed ID: 9058594
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.